But there’s a new emerging treatment of “neural grafts” that offers a more direct approach by aiming to replace the damaged brain cells themselves ... neurons don’t lose their ...

CAR-M cells generated using this protocol demonstrated strong anti-tumor effects. When co-cultured with Nalm6 (acute lymphoblastic leukemia) and Raji (B-cell lymphoma) cells, CAR-M macrophages ...

Children in a West Yorkshire prison were sometimes in cells for more than 20 hours a day ... education and contact with others", Ms Coomber said: "This isn't happening in Wetherby prison." ...

Find out how Gylden Pharma’s gold nanoparticle platform delivers targeted T cell immunity – providing a precise and durable defence against complex infectious diseases. In the fast-moving world of ...

The scientists showed that, right at the onset of mild illness, the body also produces special T cells previously known only from chronic, severe infections and tumors. Even in the case of ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

Some ingredient made by the cancer cells cultured in that lab dish was sending the lungs a message: Make more palmitate. (The scientists still aren’t sure what the signaling substance is.) ...

Credit: Juan Gaertner via Shutterstock. Chimeric antigen receptor (CAR) T cell therapies have made remarkable strides in treating high-risk B-cell malignancies since the first CAR-T, Novartis’s ...

It was a difficult time.” After his initial treatments were unsuccessful, Jonathan was offered the opportunity to enroll in a clinical trial for chimeric antigen receptor (CAR) T-cell therapy.

Orca-T, an investigational allogeneic T-cell immunotherapy, improved cGVHD-free survival compared with allo-HSCT in patients with acute leukemia or MDS in the phase 3 Precision-T trial (NCT05316701).